HomeMarket NewsCMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023

CMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023

Actionable Trade Ideas

always free

CMPX Stock Analysis: Compass Therapeutics Falls Short on EPS in Q4 2023

Unfolding Disappointment

CMPX stock - CMPX Stock Earnings: Compass Therapeutics Misses EPS for Q4 2023

Source: iQoncept / Shutterstock

Challenges Unfolding

It’s a somber scene as Compass Therapeutics (NASDAQ:CMPX) discloses its fourth-quarter 2023 outcomes.

  • The declared earnings per share stand at -11 cents, a shy step away from the anticipated -9 cents by analysts.
  • Regrettably, revenue figures for the quarter remain undisclosed by the company.

InvestorPlace Earnings unravels the developments of Compass Therapeutics using insights from TradeSmith, offering an automated peek into the quarterly earnings. Data encompassing key metrics like earnings per share and revenue comparison against analyst forecasts is disbursed without manual intervention. This system enables InvestorPlace to promptly reveal the latest financial statistics to its audience. For concerns or corrections, contact us at editor@investorplace.com.

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/cmpx-stock-earnings-compass-therapeutics-for-q4-of-2023/.

Β©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.